Brian O Mahony/ X
Jul 13, 2026, 19:47
Brian O Mahony: Two-Year Results of BBM-H901 Gene Therapy Presented at ISTH 2026
Brian O Mahony, CEO of Irish Haemophilia Society, shared a post on X:
“Feng Xue on BBM-H901 at ISTH 2026, FIX Gene therapy developed in China.
Approved in China April 2025.
Mean FIX expression after 2 years 61% Distribution :
- 76% FIX more than 40 ,
- 20% FIX less than 40,
- 10% FIX less than 20,
- 5% FIX less than 10,
- 2% FIX less than 2″
Other posts featuring Brian O Mahony on Hemostasis Today
-
Jul 13, 2026, 19:37Sara Zalghout: Connecting With Colleagues From All Over the World at ISTH 2026
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026
-
Jul 13, 2026, 17:39Pascal Boulanger: Send a Postcard to Your Lab Staff From ISTH 2026
-
Jul 13, 2026, 17:21Stefano Navarro: Presenting Our Recently Published Article at ISTH 2026
-
Jul 13, 2026, 17:12Santagata Davide: A Great Session and an Incredible Opportunity to Present Our Research at ISTH 2026
-
Jul 13, 2026, 16:26Real-World Data Across Time Reveal Important Advances in Hemophilia Treatment – ATHN
-
Jul 13, 2026, 16:19Mary Cushman: Celebrating Our Incredible ISTH Council Members in Paris